Analysts at Wells Fargo downgraded MEI Pharma, Inc. MEIP from Outperform to Market Perform.
MEI Pharma shares have dropped 80.10% over the past 52 weeks, while the S&P 500 index has surged 12.80% in the same period.
MEI Pharma's shares rose 4.66% to $2.02 in pre-market trading.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in